OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$254,000,000
-25.9%
20,0000.0%0.01%
-16.7%
Q4 2015$343,000,000
-18.5%
20,000
-39.6%
0.01%
-33.3%
Q3 2015$421,000,000
-9.3%
33,1120.0%0.01%
+12.5%
Q2 2015$464,000,00033,1120.01%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,677,194$819,0001.02%
BVF INC/IL 6,861,127$3,352,0000.16%
5AM Venture Management, LLC 1,134,511$554,0000.14%
Knott David M Jr 635,254$310,0000.13%
Nantahala Capital Management 4,819,090$2,355,0000.12%
West Family Investments, Inc. 368,910$180,0000.07%
Stonepine Capital Management, LLC 208,443$102,0000.05%
JEPPSON WEALTH MANAGEMENT, LLC 181,075$88,0000.04%
Ground Swell Capital, LLC 11,397$6,0000.01%
Point72 Asset Management, L.P. 4,200,000$2,052,0000.01%
View complete list of CIDARA THERAPEUTICS INC shareholders